BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 17, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2019
View Archived Issues
Slt-deficient F. novicida mutant shows attenuation and protects against pneumonic challenge in mice
Read More
Allist Pharmaceuticals initiates phase III FLAG study of alflutinib mesylate in NSCLC
Read More
EIP Pharma initiates phase II study of neflamapimod in cognitive dysfunction associated with DLB
Read More
Recruitment ongoing in phase I study of BI-836880 for the treatment of wAMD
Read More
Results presented from phase III EAT2TREAT study of fampridine and acetazolamide
Read More
Roche presents interim results from part 1 of FIREFISH study of risdiplam
Read More
CD73 target defined for subgroup of AML precision medicine
Read More
How mothers drive their offspring to drink
Read More
FibroGen reports phase II data for pamrevlumab in patients with DMD
Read More
Large-scale mapping uncovers protein interactions
Read More
Betta Pharmaceuticals presents BRD4 inhibitors
Read More
New CRISPR/Cas9 transgenic mice with mutated F8 gene as a model for the study of hemophilia A
Read More
Mutations in F153S of integrin beta 3 affect integrin and platelet functions
Read More
Chiesi Farmaceutici divulges new ROCK1 and ROCK2 inhibitors
Read More
Bodyweight-adjusted rivaroxaban treatment in children with acute venous thromboembolism
Read More
Chinese researchers divulge IDO1 inhibitors
Read More
Galderma describes new mTOR inhibitors
Read More
Angex Pharmaceutical discloses protein kinase inhibitors
Read More
Remegen's phase II study of RC-18 meets primary endpoint in SLE
Read More
Phase III study of niraparib maintenance therapy in first-line ovarian cancer meets primary endpoint
Read More
Pivotal Japanese studies of JTZ-951 in CKD anemia meet primary endpoints
Read More
FDA issues complete response letter for Farxiga in type 1 diabetes
Read More
Prescient initiates phase Ib trial of PTX-100 in advanced malignancies
Read More
Capricor presents 6-month data analysis from HOPE-2 trial of CAP-1002 in DMD
Read More
Neon Therapeutics reports phase Ib topline data on NEO-PV-01
Read More
